{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:25:08Z","timestamp":1790742308800,"version":"4.1.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,1]]},"DOI":"10.1093\/jac\/dkx438","type":"journal-article","created":{"date-parts":[[2017,11,5]],"date-time":"2017-11-05T23:07:00Z","timestamp":1509923220000},"page":"648-657","source":"Crossref","is-referenced-by-count":68,"title":["Activity of ceftazidime\/avibactam against problem Enterobacteriaceae and Pseudomonas aeruginosa in the UK, 2015\u201316"],"prefix":"10.1093","volume":"73","author":[{"given":"David M","family":"Livermore","sequence":"first","affiliation":[{"name":"Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, UK"},{"name":"Norwich Medical School, University of East Anglia, Norwich, Norfolk, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4678-8094","authenticated-orcid":false,"given":"Dani\u00e8le","family":"Meunier","sequence":"additional","affiliation":[{"name":"Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie L","family":"Hopkins","sequence":"additional","affiliation":[{"name":"Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Doumith","sequence":"additional","affiliation":[{"name":"Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hill","sequence":"additional","affiliation":[{"name":"Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Pike","sequence":"additional","affiliation":[{"name":"Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Staves","sequence":"additional","affiliation":[{"name":"Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Woodford","sequence":"additional","affiliation":[{"name":"Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,12,8]]},"reference":[{"key":"key\n\t\t\t\t20180216030021_dkx438-B1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/phar.1622","article-title":"The \u03b2-lactams strike back: ceftazidime-avibactam","volume":"35","author":"Zasowski","year":"2015","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/nyas.12010","article-title":"New \u03b2-lactam-\u03b2-lactamase inhibitor combinations in clinical development","volume":"1277","author":"Shlaes","year":"2013","journal-title":"Ann NY Acad Sci"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B3","doi-asserted-by":"crossref","first-page":"27960","DOI":"10.1074\/jbc.M113.485979","article-title":"Kinetics of avibactam inhibition against Class A, C, and D \u03b2-lactamases","volume":"288","author":"Ehmann","year":"2013","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B4","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1021\/acs.biochem.5b00298","article-title":"Structural basis for different substrate profiles of two closely related Class D \u03b2-lactamases and their inhibition by halogens","volume":"54","author":"Stojanoski","year":"2015","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B5","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1128\/AAC.00756-10","article-title":"Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-producing Enterobacteriaceae","volume":"55","author":"Livermore","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B6","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1093\/jac\/dkq306","article-title":"In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters","volume":"65","author":"Mushtaq","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B7","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/jac\/dkx136","article-title":"Activity of ceftolozane\/tazobactam against surveillance and \u2018problem\u2019 Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles","volume":"72","author":"Livermore","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B8","first-page":"1","article-title":"A guide to sensitivity testing. Report of the Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy","volume":"27","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijantimicag.2015.11.013","article-title":"Multicentre evaluation of a real-time PCR assay to detect genes encoding clinically relevant carbapenemases in cultured bacteria","volume":"47","author":"Ellington","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jac\/dkl481","article-title":"Multiplex PCR for rapid detection of genes encoding acquired metallo-\u03b2-lactamases","volume":"59","author":"Ellington","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B11","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/jac\/dkx173","article-title":"FRI-2 carbapenemase-producing Enterobacter cloacae complex in the UK","volume":"72","author":"Meunier","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B12","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1093\/jac\/dkw093","article-title":"Detection of the plasmid-mediated mcr-1 gene conferring colistin resistance in human and food isolates of Salmonella enterica and Escherichia coli in England and Wales","volume":"71","author":"Doumith","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B13","author":"HMMER"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B14","author":"European Molecular Biology Laboratory"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/CMR.00061-10","article-title":"Expert systems in clinical microbiology","volume":"24","author":"Winstanley","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/jac\/48.suppl_1.87","article-title":"Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes","volume":"48","author":"Livermore","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B17","author":"British Society for Antimicrobial Chemotherapy"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B18","author":"PHE English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR)"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B19","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/jac\/dkp029","article-title":"Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK","volume":"63","author":"Doumith","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B20","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1128\/AAC.00678-15","article-title":"In vitro selection of ceftazidime-avibactam resistance in Enterobacteriaceae with KPC-3 carbapenemase","volume":"59","author":"Livermore","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B21","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/cid\/ciw636","article-title":"Clinical outcomes, drug toxicity, and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections","volume":"63","author":"Shields","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1099\/jmm.0.015198-0","article-title":"PCR characterization and typing of Klebsiella pneumoniae using capsular type-specific, variable number tandem repeat and virulence gene targets","volume":"59","author":"Turton","year":"2010","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B23","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/jac\/dkx012","article-title":"OXA-48-like carbapenemases in the UK: an analysis of isolates and cases from 2007 to 2014","volume":"72","author":"Findlay","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B24","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","article-title":"The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace","volume":"215","author":"Logan","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1473-3099(16)30257-2","article-title":". Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study","volume":"17","author":"Grundmann","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B26","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1093\/jac\/dkv094","article-title":"Activity of ceftazidime\/avibactam against isogenic strains of Escherichia coli containing KPC and SHV \u03b2-lactamases with single amino acid substitutions in the \u03a9-loop","volume":"70","author":"Winkler","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B27","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1093\/jac\/dkx179","article-title":"Emergence of ceftazidime\/avibactam non-susceptibility in an MDR Klebsiella pneumoniae isolate","volume":"72","author":"Both","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1099\/jmm.0.012468-0","article-title":"Development of ertapenem resistance in a patient with mediastinitis caused by Klebsiella pneumoniae producing an extended-spectrum \u03b2-lactamase","volume":"59","author":"Skurnik","year":"2010","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1469-0691.2011.03515.x","article-title":"Rapid acquisition of decreased carbapenem susceptibility in a strain of Klebsiella pneumoniae arising during meropenem therapy","volume":"18","author":"Findlay","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B30","doi-asserted-by":"crossref","first-page":"2230.","DOI":"10.1128\/AAC.44.8.2230-2230.2000","article-title":"Are SHV \u03b2-lactamases universal in Klebsiella pneumoniae?","volume":"44","author":"Babini","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1574-6968.1992.tb05240.x","article-title":"Does high level production of SHV-type penicillinase confer resistance to ceftazidime in Enterobacteriaceae?","volume":"71","author":"Petit","year":"1992","journal-title":"FEMS Microbiol Lett"},{"key":"key\n\t\t\t\t20180216030021_dkx438-B32","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/jac\/dkw593","article-title":"In vitro activity of cefepime\/zidebactam (WCK 5222) against Gram-negative bacteria","volume":"72","author":"Livermore","year":"2017","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/3\/648\/23823640\/dkx438.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T13:00:52Z","timestamp":1570280452000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/3\/648\/4711758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,8]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,12,8]]},"published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx438","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,3]]},"published":{"date-parts":[[2017,12,8]]}}}